Avanos Medical (AVNS) Capital Expenditures (2013 - 2026)
Avanos Medical (AVNS) posted Capital Expenditures of $4.3 million for Q1 2026, up 118.61% sequentially from -$23.1 million in Q4 2025, and down 35.82% YoY from $6.7 million in Q1 2025.
Avanos Medical (AVNS) Capital Expenditures (2013 - 2026) Analysis & Trends
Avanos Medical has reported Capital Expenditures for 14 years, with the latest figure at $4.3 million in Q1 2026.
- Quarterly Capital Expenditures fell 35.82% year-over-year to $4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$800000.0 (down 109.76% YoY) and the FY2025 annual result came in at $1.6 million, down 71.43% from the prior year.
- Capital Expenditures grew to $4.3 million in Q1 2026 per AVNS's latest filing, from -$23.1 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $11.0 million in Q2 2025 and troughed at -$23.1 million in Q4 2025.
- A 5-year average of $2.0 million and a median of $4.1 million in 2022 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures sank 323.4% in 2022, then surged 156.19% in 2023.
- Over 5 years, Capital Expenditures stood at -$10.5 million in 2022, then soared by 156.19% to $5.9 million in 2023, then plunged by 225.42% to -$7.4 million in 2024, then tumbled by 212.16% to -$23.1 million in 2025, then jumped by 118.61% to $4.3 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $4.3 million, -$23.1 million, and $7.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.88 Bn | 197.28 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 126.34 Bn | 122.87 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 119.78 Bn | 110.56 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 74.35 Bn | 73.81 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.73 Bn | 47.47 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 35.36 Bn | 33.41 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.85 Bn | 31.74 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.23 Bn | 22.91 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.30 Mn |
| Mar 31, 2026 | 4.30 Mn |
| Dec 31, 2025 | -23.10 Mn |
| Dec 31, 2025 | -23.10 Mn |
| Sep 30, 2025 | 7.00 Mn |
| Sep 30, 2025 | 7.00 Mn |
| Jun 30, 2025 | 11.00 Mn |
| Jun 30, 2025 | 11.00 Mn |
| Mar 31, 2025 | 6.70 Mn |
| Mar 31, 2025 | 6.70 Mn |
| Dec 31, 2024 | -7.40 Mn |
| Dec 31, 2024 | -7.40 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 5.90 Mn |
| Jun 30, 2024 | 5.90 Mn |
| Mar 31, 2024 | 4.10 Mn |
| Mar 31, 2024 | 4.10 Mn |
| Dec 31, 2023 | 5.90 Mn |
| Dec 31, 2023 | 5.90 Mn |